Citation only
via OpenAlex
Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents
Miguel A. Pappolla, Russel Joseph Reiter, Tara Bryant‐Thomas, Burkhard Pöeggeler
Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents · 2003 · ▲ 5 citations
Abstract
Many of the recent advances in AD stem from the study of a 40-42 amino acid peptide called the amyloid beta protein (Aβ), as the essential pathologic marker of the disorder [1-2]. Our studies and those of others have shown that Aβ is central to the process of neurodegeneration in AD by initiating the production of partially reduced oxygen species and damaging essential macromolecules in the CNS. A growing body of literature links these destructive oxidative processes with some neurodegenerative aspects of AD. Herein we discuss the evidence that melatonin and related indoles can be use as potential therapeutic agents in Alzheimers disease (AD). The principal findings related to the free radical scavenging and antioxidative properties of melatonin in various paradigms of AD are presented. The hormone efficacy and the likely mechanisms involved in its ability to reduce neuronal damage mediated by oxygen-based reactive species in AD models of neurodegeneration are discussed. We will discuss the experimental data suggesting that besides the direct scavenging properties and indirect antioxidant actions of melatonin, its ability to protect neurons probably also stems from novel antiamyloidogenic properties of the hormone. Melatonin is also unique because of the ease with which it passes through the blood-brain barrier and has distinct physiological relationships to the aging process. A brief introductory discussion on the biology and neuropathology of AD is offered with a consideration of the relationship between free radicals and the pathogenesis of the disease. Keywords: Oxidative Mediated, Neurodegeneration, Neuroprotective Agents
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/1568013033358707
- Canonical
- link ↗
- Fetched
- 2026-10-31 MST
Cite this
APA
Pappolla, M.A., Reiter, R.J., Bryant‐Thomas, T., & Pöeggeler, B. (2003). Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents. <em>Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents</em>. https://doi.org/10.2174/1568013033358707
Vancouver
Pappolla MA, Reiter RJ, Bryant‐Thomas T, Pöeggeler B. Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents. Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents. 2003. doi:10.2174/1568013033358707.
BibTeX
@article{miguel2003Oxidat,
title = {Oxidative Mediated Neurodegeneration in Alzheimers Disease: Melatonin and Related Indoles as Neuroprotective Agents},
author = {Miguel A. Pappolla and Russel Joseph Reiter and Tara Bryant‐Thomas and Burkhard Pöeggeler},
journal = {Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents},
year = {2003},
doi = {10.2174/1568013033358707},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Parkinson s Disease 2013
Open access · OA
The Role of Oxidative Stress in Parkinson's Disease
Investigative Ophthalmology & Visual Science 2018
Open access · CC-BY
Potential Role of Oxidative Stress in Ocular Surface Inflammation and Dry Eye Disease
Oxidative Medicine and Cellular Longevity 2019
Open access · CC-BY
Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
Cell Transplantation 2017
Open access · CC-BY
Oxidative Stress in Stem Cell Aging
Oxidative Medicine and Cellular Longevity 2013
Open access · CC-BY
The Role of Thyroid Hormones as Inductors of Oxidative Stress and Neurodegeneration
Frontiers in Aging Neuroscience 2010
Open access · CC-BY